Metabolic Consequences of Oral Administration of 24,25-Dihydroxycholecalciferol to Uremic Dogs

24,25-dihydroxycholecalciferol [24,25-(OH)(2)D(3)], once considered a relatively inert metabolite of vitamin D(3), has been recently recognized as a metabolically active product in some species. In previous studies, we have shown that infusion of 24,25(OH)(2)D(3) into the thyroid artery of normal do...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	J Clin Invest
Hauptverfasser:	Canterbury, Janet M., Gavellas, George, Bourgoignie, Jacques J., Reiss, Eric
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Clinical Investigation 1980
Schlagworte:	Articles
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371397/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7354130/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109701
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!